Transaction DateRecipientSharesTypePriceValue
23rd June 2020Marsha Fanucci52,532Open or private purchase$0.00
23rd June 2020Marsha Fanucci14,026Open or private sale$0.00
23rd June 2020Marsha Fanucci9,847Open or private sale$0.00
23rd June 2020Terrance Mcguire4,377Open or private sale$31.54$138,062.84
23rd June 2020Marsha Fanucci33,781Open or private sale$0.00
23rd June 2020Marsha Fanucci10,240Open or private sale$0.00
3rd June 2020Mark G Currie21,720Grant/award etc.$0.00
31st May 2020George H Conrades11,857Exercise of derivative$0.00
21st February 2020William Huyett3,559Open or private sale$5.12$18,222.08
23rd January 2020Mark G Currie60,000Exercise of derivative$9.12$547,200.00
Cyclerion Therapeutics
Cyclerion Therapeutics logo

Cyclerion Therapeutics, Inc. engages in the discovery, development, and commercialization of treatments for serious and orphan diseases. Its product pipeline includes several sGC stimulators. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Ticker: CYCN
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1755237
Employees: 94
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals